189 related articles for article (PubMed ID: 29917049)
1. Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.
Diossy M; Reiniger L; Sztupinszki Z; Krzystanek M; Timms KM; Neff C; Solimeno C; Pruss D; Eklund AC; Tóth E; Kiss O; Rusz O; Cserni G; Zombori T; Székely B; Kulka J; Tímár J; Csabai I; Szallasi Z
Ann Oncol; 2018 Sep; 29(9):1948-1954. PubMed ID: 29917049
[TBL] [Abstract][Full Text] [Related]
2. Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency.
Li W; Gao L; Yi X; Shi S; Huang J; Shi L; Zhou X; Wu L; Ying J
Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):962-975. PubMed ID: 36791952
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays.
Krumm N; Khasnavis NS; Radke M; Banda K; Davies HR; Pennil C; McLean K; Paulson VA; Konnick EQ; Johnson WC; Huff G; Nik-Zainal S; Swisher EM; Lockwood CM; Salipante SJ
JCO Precis Oncol; 2023 May; 7():e2200720. PubMed ID: 37196218
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.
Harvey-Jones E; Raghunandan M; Robbez-Masson L; Magraner-Pardo L; Alaguthurai T; Yablonovitch A; Yen J; Xiao H; Brough R; Frankum J; Song F; Yeung J; Savy T; Gulati A; Alexander J; Kemp H; Starling C; Konde A; Marlow R; Cheang M; Proszek P; Hubank M; Cai M; Trendell J; Lu R; Liccardo R; Ravindran N; Llop-Guevara A; Rodriguez O; Balmana J; Lukashchuk N; Dorschner M; Drusbosky L; Roxanis I; Serra V; Haider S; Pettitt SJ; Lord CJ; Tutt ANJ
Ann Oncol; 2024 Apr; 35(4):364-380. PubMed ID: 38244928
[TBL] [Abstract][Full Text] [Related]
5. The role of homologous recombination deficiency testing in ovarian cancer and its clinical implications: do we need it?
Ngoi NYL; Tan DSP
ESMO Open; 2021 Jun; 6(3):100144. PubMed ID: 34015643
[TBL] [Abstract][Full Text] [Related]
6. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types.
Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34423229
[TBL] [Abstract][Full Text] [Related]
7. Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer.
Ding JH; Xiao Y; Yang F; Song XQ; Xu Y; Ding XH; Ding R; Shao ZM; Di GH; Jiang YZ
Sci Transl Med; 2024 Jan; 16(728):eadg7740. PubMed ID: 38170790
[TBL] [Abstract][Full Text] [Related]
8.
Huang Y; Ren S; Ding L; Jiang Y; Luo J; Huang J; Yin X; Zhao J; Fu S; Liao J
Precis Clin Med; 2024 Jun; 7(2):pbae009. PubMed ID: 38745917
[TBL] [Abstract][Full Text] [Related]
9. Alterations in homologous recombination repair genes in prostate cancer brain metastases.
Rodriguez-Calero A; Gallon J; Akhoundova D; Maletti S; Ferguson A; Cyrta J; Amstutz U; Garofoli A; Paradiso V; Tomlins SA; Hewer E; Genitsch V; Fleischmann A; Vassella E; Rushing EJ; Grobholz R; Fischer I; Jochum W; Cathomas G; Osunkoya AO; Bubendorf L; Moch H; Thalmann G; Ng CKY; Gillessen S; Piscuoglio S; Rubin MA
Nat Commun; 2022 May; 13(1):2400. PubMed ID: 35504881
[TBL] [Abstract][Full Text] [Related]
10. A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Diossy M; Sztupinszki Z; Borcsok J; Krzystanek M; Tisza V; Spisak S; Rusz O; Timar J; Csabai I; Fillinger J; Moldvay J; Pedersen AG; Szuts D; Szallasi Z
NPJ Precis Oncol; 2021 Jun; 5(1):55. PubMed ID: 34145376
[TBL] [Abstract][Full Text] [Related]
11. A Benchmark of In-House Homologous Recombination Repair Deficiency Testing Solutions for High-Grade Serous Ovarian Cancer Diagnosis.
Guarischi-Sousa R; Kroll JE; Bonaldi A; Pierry PM; Villela D; Souza CA; Silva JS; Bürger MC; Oliveira FA; de Paula MG; Meliso FM; de Almeida LG; Monfredini PM; de Oliveira AG; Milanezi F; Scapulatempo-Neto C; Yamamoto GL
Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958189
[TBL] [Abstract][Full Text] [Related]
12. BRCAness of brain lesions reflects a worse outcome for patients with metastatic breast cancer.
Ishizuka Y; Horimoto Y; Eguchi H; Murakami F; Nakai K; Onagi H; Hayashi T; Ishikawa T; Arai M; Watanabe J
Breast Cancer Res Treat; 2024 Jan; 203(1):49-55. PubMed ID: 37728693
[TBL] [Abstract][Full Text] [Related]
13. Implementing MyChoice® CDx HRD testing for the Nordics: lessons from 2021 to 2023.
Korsholm LM; Broecker V; Mirza MR; Rossing M
Acta Oncol; 2024 Mar; 63():70-75. PubMed ID: 38482597
[TBL] [Abstract][Full Text] [Related]
14. Development of Homologous Recombination Functional Assays for Targeting the DDR.
Oswald AJ; Gourley C
Cancer Treat Res; 2023; 186():43-70. PubMed ID: 37978130
[TBL] [Abstract][Full Text] [Related]
15. Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer.
Fountzilas E; Papadopoulou K; Chatzikonstantinou T; Karakatsoulis G; Constantoulakis P; Tsantikidi A; Tsaousis G; Karageorgopoulou S; Koumarianou A; Mauri D; Ntavatzikos A; Saridaki Z; Petrakis G; Fostira F; Fountzilas G; Liontos M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067228
[TBL] [Abstract][Full Text] [Related]
16. Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer.
Kim SJ; Sota Y; Naoi Y; Honma K; Kagara N; Miyake T; Shimoda M; Tanei T; Seno S; Matsuda H; Noguchi S; Shimazu K
Transl Oncol; 2021 Feb; 14(2):100986. PubMed ID: 33340887
[TBL] [Abstract][Full Text] [Related]
17. A transcriptomic model for homologous recombination deficiency in prostate cancer.
Weiner AB; Liu Y; McFarlane M; Bawa PS; Li EV; Zhao X; Li Z; Hammoud T; Hazime M; Karnes RJ; Davicioni E; Reichert ZR; Chinnaiyan AM; Lotan TL; Spratt DE; Schaeffer EM
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):659-665. PubMed ID: 34226663
[TBL] [Abstract][Full Text] [Related]
18. Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape.
Daly GR; Naidoo S; Alabdulrahman M; McGrath J; Dowling GP; AlRawashdeh MM; Hill ADK; Varešlija D; Young L
Curr Oncol Rep; 2024 Jun; ():. PubMed ID: 38822929
[TBL] [Abstract][Full Text] [Related]
19. Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation study.
Loeffler CML; El Nahhas OSM; Muti HS; Seibel T; Cifci D; van Treeck M; Gustav M; Carrero ZI; Gaisa NT; Lehmann KV; Leary A; Selenica P; Reis-Filho JS; Bruechle NO; Kather JN
medRxiv; 2023 Mar; ():. PubMed ID: 36945540
[TBL] [Abstract][Full Text] [Related]
20. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Brastianos PK; Carter SL; Santagata S; Cahill DP; Taylor-Weiner A; Jones RT; Van Allen EM; Lawrence MS; Horowitz PM; Cibulskis K; Ligon KL; Tabernero J; Seoane J; Martinez-Saez E; Curry WT; Dunn IF; Paek SH; Park SH; McKenna A; Chevalier A; Rosenberg M; Barker FG; Gill CM; Van Hummelen P; Thorner AR; Johnson BE; Hoang MP; Choueiri TK; Signoretti S; Sougnez C; Rabin MS; Lin NU; Winer EP; Stemmer-Rachamimov A; Meyerson M; Garraway L; Gabriel S; Lander ES; Beroukhim R; Batchelor TT; Baselga J; Louis DN; Getz G; Hahn WC
Cancer Discov; 2015 Nov; 5(11):1164-1177. PubMed ID: 26410082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
